Professor Mark Viant and Dr Rick Dunn of Phenome Centre Birmingham discuss metabolic phenotyping applied to medical research and the development of stratified medicine. They describe the technology alliance partnership with Thermo Fisher Scientific and the importance of Orbitrap™ and triple-quadrupole technology in experiments being undertaken to identify and quantify metabolites in both discovery and targeted mode and characterise the structure of metabolites. They also give examples of how their research into the effects of environmental changes on metabolism can be studied and understood by using mass spectrometry with an aim to developing personalised medicine.
United States
